Printer Friendly

GE introduces new system at Arab Health.

(Date: Wednesday, January 25, 2012 )

GE Healthcare has introduced its Lullaby LED phototherapy product at Arab Health, which addresses the needs of infants who are at risk of hyperbilirubinemia, a condition caused when there is too much bilirubin in the blood.

More than 50 per cent of all infants, both pre-term and full-term, are at risk of hyperbilirubinemia, said a statement from GE.

The system equips clinicians with a tool to deliver high intensity phototherapy to treat infants with hyperbilirubinemia. By utilising LED technology, power consumption and the overall replacement costs are significantly reduced, resulting in up to 80 per cent energy savings and extended bulb life.

Aziz Koleilat, general manager at GE Healthcare, Middle East, said: "The Lullaby LED phototherapy system is a great addition to our Lullaby performance product portfolio and offers a safe, efficient and cost effective solution to address one of the most common ailments in newborns."

GE Healthcare has several decades of presence in the Middle East region, and its technologies support a majority of hospitals.

Arab Health took off on January 23 and will culminate on January 26. It is now in its 37th year, and is expected to host over 70,000 healthcare professionals, featuring over 3,000 companies from around the world. -- TradeArabia News Service

Copyright 2012 www.tradearabia.com

Copyright 2012 Al Hilal Publishing & Marketing Group

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2012 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:TradeArabia (Manama, Bahrain)
Date:Jan 25, 2012
Words:233
Previous Article:Ford, Microsoft in car wellness research.
Next Article:Centre maintains think tank position.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters